Bosentan–sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology-Reference-Cited by-同舟云学术

Bosentan–sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology

Published:2012-03 Issue:3 Volume:155 Page:378-382
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

D'Alto Michele,Romeo Emanuele,Argiento Paola,Sarubbi Berardo,Santoro Giuseppe,Grimaldi Nicola,Correra Anna,Scognamiglio Giancarlo,Russo Maria Giovanna,Calabrò Raffaele

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. The incidence of congenital heart disease;Hoffmann;J Am Coll Cardiol,2002

2. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt;Wood;Br Med J,1958

3. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

4. Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications;Dimopoulos;Curr Opin Cardiol,2008

5. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease;Diller;Heart,2007

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?;International Journal of Cardiology Congenital Heart Disease;2024-09

2. Update on Eisenmenger syndrome – Review of pathophysiology and recent progress in risk assessment and management;International Journal of Cardiology Congenital Heart Disease;2024-09

3. Pulmonale Hypertonie bei Erwachsenen mit angeborenen Herzfehlern im Lichte der 2022-ESC-PAH-Leitlinien;Pneumologie;2024-05-24

4. Pulmonary arterial hypertension related to congenital heart disease with a left-to-right shunt: phenotypic spectrum and approach to management;Frontiers in Cardiovascular Medicine;2024-05-09

5. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease;Heart;2023-10-30